Much more monitoring of lower risk prostate cancer in US since 2010

According to a brief research letter in the Journal of the American Medical Association this week, there was a major increase in the application of active surveillance (AS) and watchful waiting (WW) in first-line management of prostate cancer between 2010 and 2015. … READ MORE …

Why language is important in prostate cancer management

We have emphasized this before, but we want to talk about it again because it recently came up in a general primary care journal: “active surveillance” and “watchful waiting” are often used interchangeably — by patients and their partners and by some doctors too … but they aren’t the same thing at all. … READ MORE …

From the past to the future … the appropriate use of active monitoring

A new article just published in the journal Cancer concludes that “active surveillance is underused” in the management of low-risk prostate cancer. However, one has to be careful about how one interpret the data in (and the conclusions of) this particular article. … READ MORE …

In 2004-07 most Medicare-eligible men were getting radiation therapy for first-line treatment of prostate cancer

In a second article in the new journal JAMA Oncology, researchers at the University of California Los Angeles suggest that 58 percent of all relatively recent treatment for prostate cancer was being given by radiation therapy of some type, and that indolent prostate cancer was being significantly over-treated. … READ MORE …

Use of expectant management more than doubles since 2004

According to a presentation at the Genitourinary Cancers Symposium, there has been a significant, recent increase in the numbers of men with low-risk prostate cancer who get care in the USA through some form of expectant management (active surveillance, watchful waiting, etc.). … READ MORE …

Final report of the 30-year-long Swedish study of watchful waiting in management of localized prostate cancer

Since 1977 a group of Swedish researchers has followed a prospectively evaluated, population-based cohort of 223 consecutive patients, all diagnosed clinically with localized prostate cancer, who received no treatment other than observation (“watchful waiting”) until symptomatic progression and androgen deprivation therapy (ADT) became necessary. … READ MORE …

Radical prostatectomy vs. watchful waiting: an update

Bill-Axelson et al. have just published an update of the Scandinavian Prostate Cancer Research Group’s prospective, randomized trial of watchful waiting vs. radical prostatectomy. The most recent results are somewhat worrisome.

For a detailed update on this study, please read the article entitled “Watchful waiting vs. radical surgery: the Scandinavian trial” elsewhere on this site. However, the crucial information is that at 10.8 years of follow-up there appears to have been no increase in the overall or the disease-specific survival benefit compared to the data at 8.2 years of follow-up.